BlackRock »

Palisade Bio shares owned by BlackRock

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by BlackRock

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 1.9M 1.75
2025-12-31 $4.4M 1.9M 2.35

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)

View all positions for BlackRock

Top funds holding Palisade Bio

Henderson Group
Octagon Capital Advisors
Perceptive Advisors
Ameriprise Financial
Commodore Capital
RA Capital Management
Franklin Resources
Eversept Partners
Goldman Sachs Group
Boxer Capital Management
Morgan Stanley
Adage Capital Partners GP
Dr. Jeffrey R. Jay, M.D.
Balyasny Asset Management
Federated Investors

View all funds holding Palisade Bio